• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙利度胺致直肠癌合并多发性骨髓瘤患者出现严重RR间期延长(最长间期>5.0秒):一例报告

Thalidomide-induced serious RR interval prolongation (longest interval >5.0 s) in multiple myeloma patient with rectal cancer: A case report.

作者信息

Huang Li, Kuang Yuemin, Jiang Zhiyong, Zhu Yan, Luo Xinguo, Shi Fangjing, Hu Shanshan, Gao Xinfang

机构信息

Department of Hematology, Jinhua People's Hospital, No. 228 Xinhua Street, Jinhua, Zhejiang, 32100, China.

出版信息

Open Med (Wars). 2020 Jun 11;15(1):540-544. doi: 10.1515/med-2020-0136. eCollection 2020.

DOI:10.1515/med-2020-0136
PMID:33336009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7712095/
Abstract

Primary secondary tumor increased recently with the use of immunomodulatory drugs in patients with multiple myeloma (MM). However, MM with prior diagnosis of primary secondary tumor is relatively rare. In this study, we reported an MM patient with prior diagnosis of rectal cancer. In brief, an 85-year-old man was first diagnosed with rectal cancer. Given the age, heart failure and small-cell hypochromic anemia (hemoglobin level: 54 g/L), rectal cancer resection was not advised and symptomatic treatments were performed (including sufficient iron supplementation). Eight months later, the patient was diagnosed with MM due to worsening anemia. Anemia and heart failure were corrected after three cycles of treatment with thalidomide, dexamethasone and capecitabine. Radical resection of rectal carcinoma (Hartmann) was finally performed due to acute abdominal distension. Meanwhile, RR interval prolongation (longest interval >5.0 s) and atrial fibrillation occurred in the fifth cycle treatment. One month after discontinuation of thalidomide, RR interval returned to normal range, while atrial fibrillation developed into persistent atrial fibrillation.

摘要

随着免疫调节药物在多发性骨髓瘤(MM)患者中的应用,原发性继发性肿瘤近来有所增加。然而,先前诊断为原发性继发性肿瘤的MM相对少见。在本研究中,我们报告了1例先前诊断为直肠癌的MM患者。简而言之,一名85岁男性首先被诊断为直肠癌。鉴于其年龄、心力衰竭和小细胞低色素性贫血(血红蛋白水平:54 g/L),不建议进行直肠癌切除术,而是进行了对症治疗(包括充分补充铁剂)。8个月后,患者因贫血加重被诊断为MM。使用沙利度胺、地塞米松和卡培他滨治疗3个周期后,贫血和心力衰竭得到纠正。最终因急性腹胀进行了直肠癌根治性切除术(哈特曼手术)。同时,在第5周期治疗时出现RR间期延长(最长间期>5.0 s)和心房颤动。停用沙利度胺1个月后,RR间期恢复正常范围,而心房颤动发展为持续性心房颤动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41dd/7712095/6e7a4ff8bcdf/j_med-2020-0136-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41dd/7712095/762aab378555/j_med-2020-0136-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41dd/7712095/6e7a4ff8bcdf/j_med-2020-0136-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41dd/7712095/762aab378555/j_med-2020-0136-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41dd/7712095/6e7a4ff8bcdf/j_med-2020-0136-fig002.jpg

相似文献

1
Thalidomide-induced serious RR interval prolongation (longest interval >5.0 s) in multiple myeloma patient with rectal cancer: A case report.沙利度胺致直肠癌合并多发性骨髓瘤患者出现严重RR间期延长(最长间期>5.0秒):一例报告
Open Med (Wars). 2020 Jun 11;15(1):540-544. doi: 10.1515/med-2020-0136. eCollection 2020.
2
A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report.一例因卡培他滨引起继发性QT间期延长导致心室颤动的病例报告
J Cardiol Cases. 2017 Apr 29;16(1):26-29. doi: 10.1016/j.jccase.2017.03.009. eCollection 2017 Jul.
3
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
4
Thalidomide alone or with dexamethasone for previously untreated multiple myeloma.沙利度胺单药或联合地塞米松用于既往未治疗的多发性骨髓瘤。
J Clin Oncol. 2003 Jan 1;21(1):16-9. doi: 10.1200/JCO.2003.03.139.
5
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study.硼替佐米、沙利度胺和地塞米松序贯双次自体造血干细胞移植治疗新诊断的多发性骨髓瘤(GIMEMA-MMY-3006):一项随机3期开放标签研究的长期随访分析
Lancet Haematol. 2020 Dec;7(12):e861-e873. doi: 10.1016/S2352-3026(20)30323-9.
6
[Successful treatment with thalidomide-combined therapy in an amyloidosis-complicated multiple myeloma patient refractory to bortezomib, lenalidomide, and pomalidomide].[沙利度胺联合疗法成功治疗一名对硼替佐米、来那度胺和泊马度胺难治的淀粉样变性合并多发性骨髓瘤患者]
Rinsho Ketsueki. 2018;59(3):275-280. doi: 10.11406/rinketsu.59.275.
7
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
8
Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.沙利度胺在近期诊断的多发性骨髓瘤患者自体干细胞移植前后的应用(HOVON-50):3期随机对照试验的长期结果
Lancet Haematol. 2018 Oct;5(10):e479-e492. doi: 10.1016/S2352-3026(18)30149-2.
9
10
Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study.沙利度胺、长春新碱、脂质体阿霉素和地塞米松联合用于多发性骨髓瘤的初始治疗(T-VAD多柔比星脂质体方案):一项II期多中心研究。
Ann Oncol. 2004 Jan;15(1):134-8. doi: 10.1093/annonc/mdh026.

本文引用的文献

1
Thalidomide-induced sinus bradycardia in Crohn's disease: case report and literature review.沙利度胺诱发克罗恩病患者窦性心动过缓:病例报告及文献综述
J Int Med Res. 2019 May;47(5):2228-2233. doi: 10.1177/0300060519833293. Epub 2019 Mar 5.
2
Cardiovascular Complications of Multiple Myeloma Treatment: Evaluation, Management, and Prevention.多发性骨髓瘤治疗的心血管并发症:评估、管理与预防
Curr Treat Options Cardiovasc Med. 2018 Mar 6;20(3):19. doi: 10.1007/s11936-018-0618-y.
3
The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study.
既往恶性肿瘤对多发性骨髓瘤患者二次恶性肿瘤及生存的影响:一项基于人群的研究。
Blood Adv. 2017 Nov 22;1(25):2392-2398. doi: 10.1182/bloodadvances.2017007930. eCollection 2017 Nov 28.
4
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial.来那度胺治疗背景下的第二原发性恶性肿瘤:对纳入骨髓瘤XI试验的2732例骨髓瘤患者的分析。
Blood Cancer J. 2016 Dec 9;6(12):e506. doi: 10.1038/bcj.2016.114.
5
Myocardial infarction, symptomatic third degree atrioventricular block and pulmonary embolism caused by thalidomide: a case report.沙利度胺所致心肌梗死、症状性三度房室传导阻滞及肺栓塞:一例报告
BMC Cardiovasc Disord. 2015 Dec 18;15:173. doi: 10.1186/s12872-015-0164-4.
6
Lenalidomide and second malignancies in myeloma patients.来那度胺与骨髓瘤患者的第二原发性恶性肿瘤
Lancet Oncol. 2014 Mar;15(3):253-4. doi: 10.1016/S1470-2045(14)70001-4. Epub 2014 Feb 11.
7
Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study.多参数流式细胞术检测多发性骨髓瘤微小残留病:对 MRC 骨髓瘤 IX 研究结果的影响。
J Clin Oncol. 2013 Jul 10;31(20):2540-7. doi: 10.1200/JCO.2012.46.2119. Epub 2013 Jun 3.
8
Lenalidomide after stem-cell transplantation for multiple myeloma.来那度胺用于多发性骨髓瘤患者干细胞移植后。
N Engl J Med. 2012 May 10;366(19):1770-81. doi: 10.1056/NEJMoa1114083.
9
Myeloma and second primary cancers.骨髓瘤与第二原发性癌症。
N Engl J Med. 2011 Dec 8;365(23):2241-2. doi: 10.1056/NEJMc1111010.
10
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).多发性骨髓瘤及其前体疾病(MGUS)后发生急性髓系白血病和骨髓增生异常综合征的风险。
Blood. 2011 Oct 13;118(15):4086-92. doi: 10.1182/blood-2011-05-355743. Epub 2011 Jul 27.